Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate long term safety data in patients who have completed a clinical study on SBR759 (ie: to provide long term safety and efficacy data on patients who have been titrated to achieve phosphate target within Phase II/III studies of SBR759 and completed these studies on SBR759. In addition, the study will provide access to continued SBR759 maintenance therapy for these patients. The study is an open-label, non-randomized design where patients will continue on their currently assigned dose from the previous SBR759 study)
Critère d'inclusion
- hyperphosphataemia in patients with chronic kidney disease (CKD) on haemodialysis